|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
European Organization for Research and Treatment of Cancer |
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00027794 |
Purpose
RATIONALE: Radical prostatectomy may be an effective treatment for locally advanced prostate cancer.
PURPOSE: Phase II trial to study the effectiveness of radical prostatectomy in treating patients who have locally advanced prostate cancer.
| Condition | Intervention | Phase |
|
Prostate Cancer |
Procedure: conventional surgery |
Phase II |
| MedlinePlus related topics: | Cancer Prostate Cancer |
| Study Type: | Interventional |
| Study Design: | Treatment, Open Label |
| Official Title: | Radical Prostatectomy for Locally Advanced Prostate Cancer. A Feasibility Study |
| Study Start Date: | September 2001 |
OBJECTIVES:
OUTLINE: This is a multicenter study.
Patients undergo limited pelvic lymphadenectomy and then radical retropubic prostatectomy.
Patients who are found to have pN-positive disease receive further treatment according to the investigator's discretion. Patients with pN0 disease are followed every 3 months for 1 year and then every 4 months for 1 year.
PROJECTED ACCRUAL: A total of 32-74 patients will be accrued for this study.
Eligibility
| Ages Eligible for Study: | up to 70 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Histologically confirmed adenocarcinoma of the prostate
Well or moderately differentiated tumor
PATIENT CHARACTERISTICS:
Age:
Performance status:
Life expectancy:
Hematopoietic:
Hepatic:
Renal:
Cardiovascular:
Pulmonary:
Other:
PRIOR CONCURRENT THERAPY:
Biologic therapy:
Chemotherapy:
Endocrine therapy:
Radiotherapy:
Surgery:
Contacts and Locations| Belgium | |||||
| U.Z. Gasthuisberg | |||||
| Leuven, Belgium, B-3000 | |||||
| Virga Jesse Hospital | |||||
| Hasselt, Belgium, 3500 | |||||
| Italy | |||||
| Istituto Scientifico H. San Raffaele | |||||
| Milano, Italy, 20132 | |||||
| Ospedale di Circolo e Fondazione Macchi | |||||
| Varese, Italy, 21100 | |||||
| Slovakia | |||||
| Martin Faculty Hospital | |||||
| Martin, Slovakia, 03659 | |||||
| European Organization for Research and Treatment of Cancer |
| Investigator: | Hein van Poppel, MD, PhD | U.Z. Gasthuisberg |
More Information
Clinical trial summary from the National Cancer Institute's PDQ® database 
  |
| Study ID Numbers: | CDR0000069068, EORTC-30001 |
| First Received: | December 7, 2001 |
| Last Updated: | July 23, 2008 |
| ClinicalTrials.gov Identifier: | NCT00027794 |
| Health Authority: | United States: Federal Government |
|
|
|
|